nelarabine,methotrexate,dexamethasone,daratumumab,navitoclax,asparaginase,hyaluronidase
abbvie,janssen,amphastar,novartis
['leukemia', 'hyaluronidase', 'dexamethasone', 'asparaginase', 'daratumumab', 'dinner', 'navitoclax', 'methotrexate', 'nelarabine', 'elara', ' dara ']
#ash22 t cell all continues to be a challenging disease, dismal responses in relapsed setting. how to improve outcome without increasing toxicity? addition of nelarabine upfront, daratumumab for mrd +ve, bcl2 inhibitors combinations may bring change! great talk by dr. o dwyer 
Assistant Professor @MayoCancerCare @MayoClinic Alumni @MDAndersonNews. Interest in Acute Leukemia and Chronic myeloid disorders. Views are my own